OptiBiotix Health PLC
LSE:OPTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
OptiBiotix Health PLC
LSE:OPTI
|
UK |
|
Getein Biotech Inc
SSE:603387
|
CN |
|
A
|
Atlan Holdings Bhd
KLSE:ATLAN
|
MY |
|
Guangxi Wuzhou Zhongheng Group Co Ltd
SSE:600252
|
CN |
|
I
|
IVU Traffic Technologies AG
XETRA:IVU
|
DE |
|
T
|
TAAL Enterprises Ltd
BSE:539956
|
IN |
|
Lendlease Global Commercial REIT
SGX:JYEU
|
SG |
|
M
|
Minera Valparaiso SA
SGO:MINERA
|
CL |
|
Briscoe Group Ltd
NZX:BGP
|
NZ |
|
Miroku Jyoho Service Co Ltd
TSE:9928
|
JP |
|
Wynn Resorts Ltd
NASDAQ:WYNN
|
US |
Balance Sheet
Balance Sheet Decomposition
OptiBiotix Health PLC
OptiBiotix Health PLC
Balance Sheet
OptiBiotix Health PLC
| Jul-2007 | Jul-2008 | Jul-2009 | Jul-2010 | Jul-2011 | Jul-2012 | Nov-2013 | Nov-2014 | Nov-2015 | Nov-2016 | Nov-2017 | Nov-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
3
|
2
|
3
|
1
|
1
|
0
|
1
|
2
|
1
|
1
|
1
|
|
| Cash |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
2
|
3
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
1
|
1
|
1
|
0
|
1
|
0
|
3
|
2
|
3
|
2
|
2
|
1
|
2
|
4
|
2
|
1
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
2
|
1
|
1
|
|
| Goodwill |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
4
|
4
|
3
|
9
|
14
|
8
|
7
|
7
|
|
| Other Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
1
+1%
|
1
-7%
|
1
-5%
|
1
+82%
|
2
+24%
|
0
-83%
|
6
+1 788%
|
4
-23%
|
6
+30%
|
8
+35%
|
8
+5%
|
7
-15%
|
14
+102%
|
20
+47%
|
12
-43%
|
9
-19%
|
9
-4%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+400%
|
0
-80%
|
0
N/A
|
1
+5 300%
|
0
-81%
|
0
+110%
|
1
+258%
|
1
-26%
|
1
+35%
|
1
-17%
|
1
+61%
|
2
+84%
|
2
+2%
|
2
+6%
|
1
-68%
|
1
-17%
|
1
+22%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
1
|
1
|
1
|
1
|
5
|
6
|
6
|
7
|
7
|
7
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
4
|
5
|
7
|
8
|
7
|
8
|
1
|
4
|
1
|
7
|
14
|
6
|
4
|
2
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
6
|
4
|
6
|
6
|
2
|
2
|
3
|
3
|
3
|
3
|
4
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
1
-3%
|
1
-2%
|
1
-5%
|
1
+14%
|
2
+89%
|
0
-94%
|
5
+4 812%
|
4
-22%
|
5
+29%
|
7
+43%
|
7
0%
|
5
-30%
|
12
+139%
|
18
+54%
|
11
-40%
|
9
-19%
|
8
-5%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
+1%
|
1
-7%
|
1
-5%
|
1
+82%
|
2
+24%
|
0
-83%
|
6
+1 788%
|
4
-23%
|
6
+30%
|
8
+35%
|
8
+5%
|
7
-15%
|
14
+102%
|
20
+47%
|
12
-43%
|
9
-19%
|
9
-4%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
0
|
0
|
6
|
78
|
74
|
78
|
79
|
85
|
85
|
88
|
88
|
91
|
91
|
98
|
|